We are live on ! Find out more
TM

Tikvah Management Portfolio holdings

AUM $323M
1-Year Est. Return 69.61%
This Fund
S&P 500
This Quarter Est. Return
+17.62%
1 Year Est. Return
+69.61%
3 Year Est. Return
+173.03%
5 Year Est. Return
+103.33%
10 Year Est. Return
+586.01%
AUM
$362M
AUM Growth
+$5.71M
Cap. Flow
-$42.4M
Cap. Flow %
-11.71%
Top 10 Hldgs %
91.1%
Holding
20
New
4
Increased
–
Reduced
5
Closed
2

Top Buys

Rank Stock Value
1
BIO.B icon
Bio-Rad Laboratories Class B
BIO.B
+$59.7M
2
SMRT icon
SmartRent
SMRT
+$13.4M
3
CMPOW
CompoSecure Inc Warrant
CMPOW
+$1.76M
4
VOSOW
Virtuoso Acquisition Corp. Warrant
VOSOW
+$159K

Top Sells

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$72.1M
2
QADA
QAD Inc.
QADA
+$28.7M
3
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$5.4M
4
AMZN icon
Amazon
AMZN
+$5.02M
5
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$2.6M

Sector Composition

Rank Sector Weight
1 Healthcare 25.21%
2 Technology 20.36%
3 Consumer Discretionary 17.83%
4 Communication Services 12.54%
5 Consumer Staples 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMZN icon
1
Amazon
AMZN
$2.92T
$64.6M 17.83%
375,400
-30,200
-7% -$5.02M
BIO.B icon
2
Bio-Rad Laboratories Class B
BIO.B
$63.4M 17.5%
+98,357
New +$59.7M
QADA
3
DELISTED
QAD Inc.
QADA
$51.1M 14.1%
587,010
-393,000
-40% -$28.7M
INOV
4
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$39.6M 10.92%
1,161,056
-84,000
-7% -$2.6M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.36T
$30.7M 8.48%
251,680
– –
QTRX icon
6
Quanterix
QTRX
$164M
$20.3M 5.59%
345,409
-26,300
-7% -$1.53M
SPY icon
7
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$16.7M 4.61%
38,994
-4,830
-11% -$2.02M
SMRT icon
8
SmartRent
SMRT
$195M
$15.2M 4.21%
+1,238,200
New +$13.4M
GOOG icon
9
Alphabet (Google) Class C
GOOG
$4.36T
$14.7M 4.06%
117,380
– –
BNFT
10
DELISTED
Benefitfocus, Inc.
BNFT
$13.7M 3.8%
975,104
– –
LAB icon
11
Standard BioTools
LAB
$340M
$7.7M 2.13%
1,250,000
– –
QADB
12
DELISTED
QAD Inc. Class B
QADB
$7.41M 2.05%
85,957
– –
VWO icon
13
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$5.52M 1.52%
101,580
– –
STRA icon
14
Strategic Education
STRA
$1.85B
$5.13M 1.42%
67,489
– –
CMPOW
15
DELISTED
CompoSecure Inc Warrant
CMPOW
$2.4M 0.66%
+1,465,003
New +$1.76M
INDA icon
16
iShares MSCI India ETF
INDA
$6.89B
$2.09M 0.58%
47,200
– –
IAU icon
17
iShares Gold Trust
IAU
$62.9B
$1.69M 0.47%
50,250
– –
VOSOW
18
DELISTED
Virtuoso Acquisition Corp. Warrant
VOSOW
$299K 0.08%
+175,000
New +$159K
BIO icon
19
Bio-Rad Laboratories Class A
BIO
$8.71B
– –
-126,282
Closed -$72.1M
BRK.A icon
20
Berkshire Hathaway Class A
BRK.A
$1.1T
– –
-14
Closed -$5.4M

Similar funds

GIM
Gold Investment Management Edmonton, Alberta, Canada $323M AUM 38.72% 1-Year Est. Return
CRI
Commonwealth Retirement Investments Richmond, Virginia $323M AUM 24.17% 1-Year Est. Return
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
BEP
Bluescape Energy Partners Dallas, Texas $322M AUM 18.33% 1-Year Est. Return
AIA
AIMZ Investment Advisors Los Altos, California $324M AUM 18.77% 1-Year Est. Return
FAL
Focused Alpha LLC Denver, Colorado $324M AUM
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Tikvah Management's Q2 2021 Portfolio in Review

As of Q2 2021, Tikvah Management held 20 positions worth $362M, up 1.6% from $357M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Tikvah Management withdrew a net $42.4M in Q2 2021, closing 2 positions and reducing 5 holdings. Its most notable exit was Bio-Rad Laboratories Class A, an estimated $72.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tikvah Management opened a new position in Bio-Rad Laboratories Class B worth $63.4M.

  • Tikvah Management's largest Q2 2021 buy was Bio-Rad Laboratories Class B: 98,357 shares worth $63.4M.
  • Tikvah Management's biggest Q2 2021 reduction was QAD Inc., cutting an estimated $28.7M.
  • Tikvah Management fully exited Bio-Rad Laboratories Class A in Q2 2021, selling an estimated $72.1M.
  • Tikvah Management's ten largest holdings make up 91% of its $362M portfolio in Q2 2021.
  • Tikvah Management opened 4 new positions and closed 2 in Q2 2021.
  • Tikvah Management's portfolio value rose 1.6% quarter-over-quarter to $362M.

Based on Tikvah Management's 13F filing for Q2 2021, filed 16 Aug 2021.